This joint civil society submission warns that restrictive laws and funding barriers are undermining the rights and operations of organisations supporting people who use drugs and other marginalised communities.
C-EHRN highlights shifting drug trends across Europe, noting the rising prevalence of polydrug use, potent synthetic substances, and the critical need for adapted harm reduction services.
The Drug Policy Alliance says shifting from fear-based narratives to positive, public health messaging is key to building safer and healthier communities.
IDPC and civil society partners highlight the deep-rooted racial inequalities in drug law enforcement, urging for reforms to dismantle systemic harm and discrimination.
This report summarises major topics from the meeting, such as the current geopolitical climate and the importance of rights-based policy for vulnerable communities.
UNAIDS, UNDP and INPUD synthesise models to support rights-based HIV responses, offer key principles, good practices, and expert insights from people who use drugs and specialists.
EHRA and partners analyse how shrinking civic space and punitive legal frameworks are undermining community-led HIV and TB responses in the region, directly impacting LGBTQI+ people, people who use drugs, sex workers, and people living with HIV.
The Scottish Drugs Forum published a human-centred list of recommendations for the incoming Scottish government, emphasising courageous policymaking and leading with compassion.
EHRA provide a comparative assessment of harm reduction across Southeastern Europe, positioning political commitment and financing as critical to closing gaps.
Intersecção discusses how drug prohibition fuels deforestation, violence, and inequality across the region, linking the 'war on drugs' to the global climate crisis and calling for ecological harm reduction and rights-based regulation.
This collection examines Europe’s harm reduction journey, including early successes, uneven implementation, securitisation, stigma and medicalisation; and proposes a reframed, people-led approach centring wellbeing, acknowledging drug-use benefits, and advancing rights-based reforms.
